ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 274,48
-0,27%
Dow Jones
42 840,26
1,18%
DAX
19 884,75
-0,57%
Brent Oil
72,72
0,00%
Bitcoin
97 501,69
-0,26%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Alpha Tau Medical Ltd (DRTS) Cours

Alpha Tau Medical Ltd

Alpha Tau Medical Ltd (DRTS)

NASDAQ
3,10
-0,025
(-0,80%)
Fermé 21 Décembre 10:00PM
Retardé de 15 minutes
3,10
0,00
(0,00%)
Après les heures de négociation: 12:00AM
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
3,10
Prix Achat
2,90
Prix Vente
16,00
Volume échangé
26 104
3,06 Fourchette du Jour 3,1499
1,75 Plage de 52 semaines 3,40
Cap du marché
215,979M
Clôture Veille
3,125
Ouverture
3,12
Dernière Transaction
10
@
3.09
Dernière heure de transaction
Volume financier
US$ 80 837
VWAP
3,0967
Volume moyen (3 m)
35 967
Actions en circulation
69 670 612
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-7,41
Bénéfice par action (BPA)
-0,42
Chiffre d'affairess
-
Bénéfice net
-29,16M

À propos de Alpha Tau Medical Ltd

Alpha Tau Medical focuses on R&D, and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer tumors. The Alpha DaRT technology was developed in 2003 at Tel Aviv University. Alpha Tau Medical focuses on R&D, and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer tumors. The Alpha DaRT technology was developed in 2003 at Tel Aviv University.

Secteur
Surgical,med Instr,apparatus
Industrie
Surgical,med Instr,apparatus
Site Web
www.alphatau.com
Siège social
Jerusalem, Jerusalem, Isr
Fondé
-
Alpha Tau Medical Ltd est coté dans le secteur Surgical,med Instr,apparatus de la NASDAQ avec le ticker DRTS. Le dernier cours de clôture d'Alpha Tau Medical était de US$3,13. Au cours de la dernière année, les actions de Alpha Tau Medical ont été négociées dans une fourchette de prix de US$ 1,75 à US$ 3,40.

Alpha Tau Medical compte actuellement 69 670 612 actions en circulation. La capitalisation boursière d'Alpha Tau Medical est de US$217,72 million. Alpha Tau Medical a un ratio cours/bénéfice (ratio PE) de -7.41.

DRTS Dernières nouvelles

Plus de nouvelles

Alpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update Day

JERUSALEM, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

18 Décembre 2024
GlobeNewswire Inc.

Alpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir Jakobsohn Stepping Down, Staying on as Advisor

JERUSALEM, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW), ("Alpha Tau" or the "Company"), the developer of the innovative alpha-radiation cancer therapy Alpha...

17 Décembre 2024
GlobeNewswire Inc.

Alpha Tau to Present at the 43rd Annual J.P. Morgan Healthcare Conference

JERUSALEM, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

11 Décembre 2024
GlobeNewswire Inc.

Alpha Tau to Participate in Ladenburg’s Oncology Innovators & Investors Symposium

JERUSALEM, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

06 Décembre 2024
GlobeNewswire Inc.

Alpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate Update

- Alpha DaRT® accepted into the prestigious Total Product Life Cycle Advisory Program (TAP) of the FDA, to accelerate market access to the Alpha DaRT® for patients with recurrent glioblastoma...

19 Novembre 2024
GlobeNewswire Inc.

Alpha Tau to Participate in Citi’s 2024 Global Healthcare Conference and Piper Sandler’s 36th Annual Healthcare Conference

JERUSALEM, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

13 Novembre 2024
GlobeNewswire Inc.

Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme

JERUSALEM, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-emitters cancer therapy Alpha...

21 Octobre 2024
GlobeNewswire Inc.

Alpha Tau Treats First Patient with Recurrent Lung Cancer

JERUSALEM, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

10 Octobre 2024
GlobeNewswire Inc.

Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC

JERUSALEM, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

20 Septembre 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

22 Août 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.030.9771986970683.073.22.88426363.13382278CS
40.834.78260869572.33.22.3620542.92167672CS
120.7833.62068965522.323.22.11359672.64363489CS
260.8739.01345291482.233.21.75336832.42325264CS
520.26.896551724142.93.41.75343652.62670225CS
156-8.45-73.160173160211.5520.651.75934898.8444229CS
260-8.45-73.160173160211.5520.651.75934898.8444229CS

DRTS - Frequently Asked Questions (FAQ)

What is the current Alpha Tau Medical share price?
The current share price of Alpha Tau Medical is US$ 3,10
How many Alpha Tau Medical shares are in issue?
Alpha Tau Medical has 69 670 612 shares in issue
What is the market cap of Alpha Tau Medical?
The market capitalisation of Alpha Tau Medical is USD 217,72M
What is the 1 year trading range for Alpha Tau Medical share price?
Alpha Tau Medical has traded in the range of US$ 1,75 to US$ 3,40 during the past year
What is the PE ratio of Alpha Tau Medical?
The price to earnings ratio of Alpha Tau Medical is -7,41
What is the reporting currency for Alpha Tau Medical?
Alpha Tau Medical reports financial results in USD
What is the latest annual profit for Alpha Tau Medical?
The latest annual profit of Alpha Tau Medical is USD -29,16M
What is the registered address of Alpha Tau Medical?
The registered address for Alpha Tau Medical is KIRYAT HAMADA ST. 5, JERUSALEM, JERUSALEM, 9777605
What is the Alpha Tau Medical website address?
The website address for Alpha Tau Medical is www.alphatau.com
Which industry sector does Alpha Tau Medical operate in?
Alpha Tau Medical operates in the SURGICAL,MED INSTR,APPARATUS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MYSZMy Size Inc
US$ 4,2001
(211,12%)
121,03M
NVNINVNI Group Ltd
US$ 8,26
(209,36%)
78,06M
TPICTPI Composites Inc
US$ 2,45
(100,82%)
34M
ICGIntchains Group Ltd
US$ 8,77
(88,60%)
527,94k
HSDTHelius Medical Technologies Inc
US$ 0,884851
(84,34%)
121,95M
CYNCYNGN Inc
US$ 0,4603
(-71,41%)
27,91M
MTEMMolecular Templates Inc
US$ 0,1502
(-57,09%)
8,75M
PRFXPainReform Ltd
US$ 5,15
(-53,85%)
2,94M
GALTGalectin Therapeutics Inc
US$ 1,03
(-48,50%)
9,27M
BCABBioAtla Inc
US$ 0,6923
(-41,82%)
6,25M
EDBLEdible Garden AG Inc
US$ 0,24
(65,06%)
354,32M
APTOAptose Biosciences Inc
US$ 0,28
(64,51%)
305,1M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,606999
(6,49%)
292,16M
NVDANVIDIA Corporation
US$ 134,70
(3,08%)
287,21M
PLTRPalantir Technologies Inc
US$ 80,55
(8,54%)
277,63M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
DRTS
Alpha Tau Medical
AQSE
DAXX.GB
Amundi DAX III UCITS ETF...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés